Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost
- PMID: 16904906
- DOI: 10.1016/j.pep.2006.06.024
Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost
Abstract
Automation and miniaturization are key issues of high-throughput research projects in the post-genomic era. The implementation of robotics and parallelization has enabled researchers to process large numbers of protein targets for structural studies in a short time with reasonable cost efficiency. However, the cost of implementing the robotics and parallelization often prohibit their use in the traditional academic laboratory. Fortunately, multiple groups have made significant efforts to minimize the cost of heterologous protein expression for the production of protein samples in quantities suitable for high resolution structural studies. In this review, we describe recent efforts to continue to minimize the cost for the parallel processing of multiple protein targets and focus on those materials and strategies that are highly suitable for the traditional academic laboratory.
Similar articles
-
A flexible and economical medium-throughput strategy for protein production and crystallization.Acta Crystallogr D Biol Crystallogr. 2005 Oct;61(Pt 10):1378-85. doi: 10.1107/S0907444905023590. Epub 2005 Sep 28. Acta Crystallogr D Biol Crystallogr. 2005. PMID: 16204890
-
Parallel gene cloning and protein production in multiple expression systems.Biotechnol Prog. 2009 Nov-Dec;25(6):1582-6. doi: 10.1002/btpr.274. Biotechnol Prog. 2009. PMID: 19637396
-
Complex Reconstitution and Characterization by Combining Co-expression Techniques in Escherichia coli with High-Throughput.Adv Exp Med Biol. 2016;896:43-58. doi: 10.1007/978-3-319-27216-0_4. Adv Exp Med Biol. 2016. PMID: 27165318 Review.
-
Gateway-compatible vectors for high-throughput protein expression in pro- and eukaryotic cell-free systems.J Biotechnol. 2015 Feb 10;195:1-7. doi: 10.1016/j.jbiotec.2014.12.006. Epub 2014 Dec 19. J Biotechnol. 2015. PMID: 25529348
-
Advanced genetic strategies for recombinant protein expression in Escherichia coli.J Biotechnol. 2005 Jan 26;115(2):113-28. doi: 10.1016/j.jbiotec.2004.08.004. J Biotechnol. 2005. PMID: 15607230 Review.
Cited by
-
The mode of action of the Protein tyrosine phosphatase 1B inhibitor Ertiprotafib.PLoS One. 2020 Oct 2;15(10):e0240044. doi: 10.1371/journal.pone.0240044. eCollection 2020. PLoS One. 2020. PMID: 33007022 Free PMC article.
-
Accelerated pharmaceutical protein development with integrated cell free expression, purification, and bioconjugation.Sci Rep. 2018 Aug 10;8(1):11967. doi: 10.1038/s41598-018-30435-4. Sci Rep. 2018. PMID: 30097621 Free PMC article.
-
Structure-function analysis of the filamentous actin binding domain of the neuronal scaffolding protein spinophilin.FEBS J. 2008 Jan;275(1):59-68. doi: 10.1111/j.1742-4658.2007.06171.x. Epub 2007 Nov 20. FEBS J. 2008. PMID: 18028445 Free PMC article.
-
Conservation of helical bundle structure between the exocyst subunits.PLoS One. 2009;4(2):e4443. doi: 10.1371/journal.pone.0004443. Epub 2009 Feb 13. PLoS One. 2009. PMID: 19214222 Free PMC article.
-
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.Biochemistry. 2008 Nov 25;47(47):12346-56. doi: 10.1021/bi801308y. Biochemistry. 2008. PMID: 18954090 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials